We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Vitamin E and Vitamin K2 can interact. Vitamin E at supplement doses measurably lowered vitamin K status in adults with normal clotting. Menaquinone is taken to carboxylate osteocalcin and matrix Gla protein — the very reaction high-dose vitamin E impairs — so the two work against each other. Keep vitamin E at or below 400 IU/day if you are also taking K2, and separate them by a few hours to reduce absorption competition. Do not use this pairing to self-manage clotting: if you are on an anticoagulant, both belong in a conversation with the prescriber.
Vitamin E at supplement doses measurably lowered vitamin K status in adults with normal clotting. Menaquinone is taken to carboxylate osteocalcin and matrix Gla protein — the very reaction high-dose vitamin E impairs — so the two work against each other.
High-dose alpha-tocopherol interferes with vitamin K-dependent gamma-carboxylation, and its quinone metabolite competes with vitamin K in that pathway. The two are also fat-soluble vitamins competing for the same absorption route.
What to do: Keep vitamin E at or below 400 IU/day if you are also taking K2, and separate them by a few hours to reduce absorption competition. Do not use this pairing to self-manage clotting: if you are on an anticoagulant, both belong in a conversation with the prescriber.
Dose matters: >400 IU/day vitamin E. Minimal risk: <200 IU/day vitamin E.
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.